Matches in SemOpenAlex for { <https://semopenalex.org/work/W3200534188> ?p ?o ?g. }
- W3200534188 endingPage "e2125328" @default.
- W3200534188 startingPage "e2125328" @default.
- W3200534188 abstract "Many patients with metastatic cancer receive high-cost, low-value care near the end of life. Identifying patients with a high likelihood of receiving low-value care is an important step to improve appropriate end-of-life care.To analyze patterns of care and interventions during terminal hospitalizations and examine whether care management is associated with sociodemographic status among adult patients with metastatic cancer at the end of life.This retrospective, population-based cross-sectional study used data from the Healthcare Cost and Utilization Project to analyze all-payer, encounter-level information from multiple inpatient centers in the US. All utilization and hospital charge records from national inpatient sample data sets between January 1, 2010, and December 31, 2017 (n = 58 761 097), were screened. The final cohort included 21 335 patients 18 years and older at inpatient admission who had a principal diagnosis of metastatic cancer and died during hospitalization. Data for the current study were analyzed from January 1, 2010, to December 31, 2017.Patient demographic characteristics, patient insurance status, hospital location, and hospital teaching status.Receipt of systemic therapy (including chemotherapy and immunotherapy), receipt of invasive mechanical ventilation, emergency department (ED) admission, time from hospital admission to death, and total charges during a terminal hospitalization.Among 21 335 patients with metastatic cancer who had terminal hospitalizations between 2010 and 2017, the median age was 65 years (interquartile range, 56-75 years); 54.0% of patients were female; 0.5% were American Indian, 3.3% were Asian or Pacific Islander, 14.1% were Black, 7.5% were Hispanic, 65.9% were White, and 3.1% were identified as other; 58.2% were insured by Medicare or Medicaid, and 33.2% were privately insured. Overall, 63.2% of patients were admitted from the ED, 4.6% received systemic therapy, and 19.2% received invasive mechanical ventilation during hospitalization. Racial and ethnic minority patients had a higher likelihood of being admitted from the ED (Asian or Pacific Islander patients: odds ratio [OR], 1.43 [95% CI, 1.20-1.72]; P < .001; Black patients: OR, 1.39 [95% CI, 1.27-1.52]; P < .001; and Hispanic patients: OR, 1.45 [95% CI, 1.28-1.64]; P < .001), receiving invasive mechanical ventilation (Black patients: OR, 1.59 [95% CI, 1.44-1.75]; P < .001), and incurring higher total charges (Asian or Pacific Islander patients: OR, 1.35 [95% CI, 1.13-1.60]; P = .001; Black patients: OR, 1.23 [95% CI, 1.13-1.34]; P < .001; and Hispanic patients: OR, 1.50 [95% CI, 1.34-1.69]; P < .001) compared with White patients. Privately insured patients had a lower likelihood of being admitted from the ED (OR, 0.47 [95% CI, 0.44-0.51]; P < .001), receiving invasive mechanical ventilation (OR, 0.75 [95% CI, 0.69-0.82]; P < .001), and incurring higher total charges (OR, 0.64 [95% CI, 0.59-0.68]; P < .001) compared with Medicare and Medicaid beneficiaries.In this study, patients with metastatic cancer from racial and ethnic minority groups and those with Medicare or Medicaid coverage were more likely to receive low-value, aggressive interventions at the end of life. Further studies are needed to evaluate the underlying factors associated with disparities at the end of life to implement prospective interventions." @default.
- W3200534188 created "2021-09-27" @default.
- W3200534188 creator A5012546988 @default.
- W3200534188 creator A5014353971 @default.
- W3200534188 creator A5024962229 @default.
- W3200534188 creator A5040332558 @default.
- W3200534188 creator A5045609775 @default.
- W3200534188 creator A5052169770 @default.
- W3200534188 creator A5056322583 @default.
- W3200534188 creator A5079162702 @default.
- W3200534188 creator A5091004438 @default.
- W3200534188 date "2021-09-22" @default.
- W3200534188 modified "2023-10-01" @default.
- W3200534188 title "Disparities in Care Management During Terminal Hospitalization Among Adults With Metastatic Cancer From 2010 to 2017" @default.
- W3200534188 cites W1171401055 @default.
- W3200534188 cites W1484298347 @default.
- W3200534188 cites W1493892377 @default.
- W3200534188 cites W1907616122 @default.
- W3200534188 cites W1984949566 @default.
- W3200534188 cites W1986469036 @default.
- W3200534188 cites W1999898631 @default.
- W3200534188 cites W2030683208 @default.
- W3200534188 cites W2034569750 @default.
- W3200534188 cites W2040530001 @default.
- W3200534188 cites W2043696784 @default.
- W3200534188 cites W2053792902 @default.
- W3200534188 cites W2058315460 @default.
- W3200534188 cites W2060724440 @default.
- W3200534188 cites W2075802693 @default.
- W3200534188 cites W2096552494 @default.
- W3200534188 cites W2104662184 @default.
- W3200534188 cites W2108805951 @default.
- W3200534188 cites W2112194086 @default.
- W3200534188 cites W2128969353 @default.
- W3200534188 cites W2135894244 @default.
- W3200534188 cites W2137401089 @default.
- W3200534188 cites W2146468725 @default.
- W3200534188 cites W2147878219 @default.
- W3200534188 cites W2159117431 @default.
- W3200534188 cites W2171727511 @default.
- W3200534188 cites W2272748788 @default.
- W3200534188 cites W2302801691 @default.
- W3200534188 cites W2397623993 @default.
- W3200534188 cites W2492816969 @default.
- W3200534188 cites W2497035007 @default.
- W3200534188 cites W2510742244 @default.
- W3200534188 cites W2549006299 @default.
- W3200534188 cites W2576641900 @default.
- W3200534188 cites W2616966528 @default.
- W3200534188 cites W2729007582 @default.
- W3200534188 cites W2768808119 @default.
- W3200534188 cites W2802263553 @default.
- W3200534188 cites W2888678470 @default.
- W3200534188 cites W2976155552 @default.
- W3200534188 cites W2981726175 @default.
- W3200534188 cites W3000427375 @default.
- W3200534188 cites W3004847952 @default.
- W3200534188 cites W3016550038 @default.
- W3200534188 cites W3036852370 @default.
- W3200534188 cites W3036859778 @default.
- W3200534188 cites W3037300287 @default.
- W3200534188 cites W3041007753 @default.
- W3200534188 cites W4205159828 @default.
- W3200534188 cites W4232759447 @default.
- W3200534188 cites W4237681664 @default.
- W3200534188 cites W4242791122 @default.
- W3200534188 cites W4253413376 @default.
- W3200534188 cites W4296976768 @default.
- W3200534188 doi "https://doi.org/10.1001/jamanetworkopen.2021.25328" @default.
- W3200534188 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8459194" @default.
- W3200534188 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34550384" @default.
- W3200534188 hasPublicationYear "2021" @default.
- W3200534188 type Work @default.
- W3200534188 sameAs 3200534188 @default.
- W3200534188 citedByCount "5" @default.
- W3200534188 countsByYear W32005341882022 @default.
- W3200534188 countsByYear W32005341882023 @default.
- W3200534188 crossrefType "journal-article" @default.
- W3200534188 hasAuthorship W3200534188A5012546988 @default.
- W3200534188 hasAuthorship W3200534188A5014353971 @default.
- W3200534188 hasAuthorship W3200534188A5024962229 @default.
- W3200534188 hasAuthorship W3200534188A5040332558 @default.
- W3200534188 hasAuthorship W3200534188A5045609775 @default.
- W3200534188 hasAuthorship W3200534188A5052169770 @default.
- W3200534188 hasAuthorship W3200534188A5056322583 @default.
- W3200534188 hasAuthorship W3200534188A5079162702 @default.
- W3200534188 hasAuthorship W3200534188A5091004438 @default.
- W3200534188 hasBestOaLocation W32005341881 @default.
- W3200534188 hasConcept C119060515 @default.
- W3200534188 hasConcept C121608353 @default.
- W3200534188 hasConcept C126322002 @default.
- W3200534188 hasConcept C136764020 @default.
- W3200534188 hasConcept C159110408 @default.
- W3200534188 hasConcept C167135981 @default.
- W3200534188 hasConcept C194828623 @default.
- W3200534188 hasConcept C27415008 @default.
- W3200534188 hasConcept C2778979077 @default.
- W3200534188 hasConcept C2780724011 @default.